For the second quarter of FY2026, net sales were 297.16 billion yen (up 23.3% YoY), and operating profit was 4.39 billion yen (up 90.8% YoY).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4554","jir_company_name":"Fujii Pharmaceutical Industry Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4554-20260512-01.pdf","jir_short_summary":"For the second quarter of FY2026, net sales were 297.16 billion yen (up 23.3% YoY), and operating profit was 4.39 billion yen (up 90.8% YoY).","jir_summary":"### Performance Overview\nIn the second quarter of FY2026, consolidated net sales were 29,716 million yen (up 23.3% YoY), driven by the steady progress of new drugs in the women's healthcare field and biosimilar businesses. Operating profit was a significant 4,398 million yen (up 90.8% YoY), while net profit attributable to owners of the parent declined to 713 million yen (down 44.6% YoY) due to recording valuation losses on investment securities. Total assets reached 97,938 million yen, net assets increased to 51,363 million yen, and the equity ratio improved to 52.4%.\n\n### Dividend Status and Future Outlook\nThe annual dividend forecast for FY2026 is a total of 49 yen (an increase from the previous year), with a planned year-end dividend of 26 yen. The full-year earnings forecast remains unchanged from the plan announced on February 5, 2026, projecting net sales of 59,250 million yen (up 14.7% YoY), operating profit of 6,120 million yen (up 22.6% YoY), and net income attributable to owners of the parent of 2,240 million yen (down 25.3% YoY).","jir_financial_highlights":"Net Sales: 29,716 million yen (Up 23.3% YoY)\nOperating Profit: 4,398 million yen (Up 90.8% YoY)\nOrdinary Income: 4,263 million yen (Up 92.9% YoY)\nNet Profit Attributable to Owners of Parent: 713 million yen (Down 44.6% YoY)\nTotal Assets: 97,938 million yen (Increase compared to the previous consolidated fiscal year-end)\nNet Assets: 51,363 million yen (Increase compared to the previous consolidated fiscal year-end)\nEquity Ratio: 52.4% (Increase compared to the previous consolidated fiscal year-end)\nNumber of Shares Outstanding (at end of period): 26,541,100 shares (Increase compared to the same period last year)\nNumber of Treasury Shares (at end of period): 421,339 shares (Decrease compared to the same period last year)","jir_category":"","jir_hashtags":"#FujiiPharmaceutical, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: 29,716 million yen (up 23.3% YoY)\nOperating Profit: 4,398 million yen (up 90.8% YoY)\nNet Income Attributable to Owners of Parent: 713 million yen (down 44.6% YoY)","jir_meta_title":"\u3010Fujii Pharmaceutical\u3011FY2026 Q2 Financial Results | Sales: 297 billion yen (+23.3% YoY), Operating Profit: 4.4 billion yen Increase","jir_meta_description":"Fujii Pharmaceutical's FY2026 second quarter consolidated financial results. Net sales of 29,716 million yen (up 23.3%), operating profit of 4,398 million yen (up 90.8%). The dividend forecast is 49 yen annually, with no change to the full-year outlook.","jir_og_title":"\u3010Fujii Pharmaceutical\u3011FY2026 Q2 Financial Results | Sales: 29.7 billion yen (+23.3%)","jir_og_description":"FY2026 second quarter financial summary. Net sales of 29,716 million yen, operating profit of 4,398 million yen. The planned annual dividend is 49 yen.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trend (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Interim\\\",\\\"FY2026 Interim\\\",\\\"FY2025 Full Year Forecast\\\",\\\"FY2026 Full Year Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[24095,29716,51800,59250],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Profit Trend (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Interim\\\",\\\"FY2026 Interim\\\",\\\"FY2025 Full Year Forecast\\\",\\\"FY2026 Full Year Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit\\\",\\\"data\\\":[2305,4398,4980,6120],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"ordinary_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Ordinary Income Trend (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Interim\\\",\\\"FY2026 Interim\\\",\\\"FY2025 Full Year Forecast\\\",\\\"FY2026 Full Year Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Ordinary Income\\\",\\\"data\\\":[2209,4263,4460,5880],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent (million yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Interim\\\",\\\"FY2026 Interim\\\",\\\"FY2025 Full Year Forecast\\\",\\\"FY2026 Full Year Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[1287,713,3000,2240],\\\"backgroundColor\\\":\\\"#76b7b2\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"dividend_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Annual Dividends (Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025\\\",\\\"FY2026 Forecast\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Annual Dividends\\\",\\\"data\\\":[45.5,49],\\\"backgroundColor\\\":\\\"#59a14f\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":17504,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48418","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n